Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib in recurrent or progressive glioblastoma multiforme
2007-002142-37Phase 2Completed
- Sponsor
- Medical University of Innsbruck
- Start
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sunitinib in glioblastoma (GBM), sponsored by Medical University of Innsbruck. Primary endpoint: Median time to tumor progression. Started Jul 2007; status: completed.
02
Drugs
sunitinib
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on 2007-002142-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002142-37.